Ensuring equitable and sustainable access to medicines through a secure and resilient supply,  10 November 2022

Programme

09:15-10:00

Registration and welcome coffee


10:00 - 10:05
Welcome speech

Martina Brzková – Health Attaché, Permanent Representation of the Czech Republic to the European Union

10:05 -10:15

Introductory remarks

Jakub Dvořáček – Deputy Minister, Ministry of Health of the Czech Republic

Elisabeth Stampa – Medicines for Europe President and CEO Medichem


10:15-11:20

Session 1: Sustainable and equitable access to medicines in Central and Eastern Europe

Equitable access to medicines and the sustainability of healthcare systems remains a challenge for many European governments. In this context, off-patent medicines play an essential role in promoting pharmaceutical innovation and, through competition contribute massively to the affordability, sustainability, and accessibility of healthcare systems. The greater use of generic and biosimilar medicines in the CEE region could be a catalyst to dramatically improve access to medicines and to improve health outcomes, as found in the recent Medicines for Europe report “Removing access barriers in Central and Eastern Europe: How can we ensure equitable access to medicines for all European patients?”

MODERATOR: Dave Keating - Brussels Correspondent, France 24

PANELLISTS:

Jakub Dvořáček - Deputy Minister, Ministry of Health of the Czech Republic

Vera Pataki - Head of International Market Access, EGIS and Chair of the CEE Network, Medicines for Europe

Zoltán Kaló - Professor of Health Economics at Center for Health Technology Assessment, Semmelweis University 

Gergely Németh - Project Manager, EURIPID at the National Institute of Health Insurance Fund Management

(NEAK) 

Robert HejzákBoard Chair, National Association of Patient Organizations (NAPO), Czech Republic

11:20-11:40 Coffee break 

 11:40-12:45

Session 2: Increasing Manufacturing Resilience for security of supply and equitable access

Cost-containment and the Industrial consolidation of the sector run counter to the EU’s commitment to increase manufacturing resilience and diversity and reduce reliance on third countries. To reverse industrial consolidation and promote open strategic autonomy in medicines manufacturing, the Czech Presidency can stimulate progress on a policy environment that solidifies security of supply for equitable access to medicines.

MODERATOR: Dave Keating – Brussels Correspondent, France 24

PANELLISTS: 

Giacomo Mattinò - Head of Unit, Food, Retail, Health, DG Internal Market, Industry, Entrepreneurship and SMEs, European Commission

Marian Piecha - Deputy Minister, Ministry of Industry and Trade of the Czech Republic

Elisabeth Stampa - Medicines for Europe President and CEO Medichem

Steffen Denzinger  - President European Fine Chemicals Group (EFCG) and Director Business Development          Actives & Formulation Merck KGaA

Soňa Porubská - Head of Corporate Affairs Zentiva Global and ČAFF Board member

12:45-13:00

Concluding remarks

Marian Piecha - Deputy Minister, Ministry of Industry and Trade of the Czech Republic

Philippe Drechsle - Vice President EU Portfolio, TEVA and Medicines for Europe Executive Committee          member

13:00 Buet lunch

Sign in to Google to save your progress. Learn more
Untitled Title
Untitled Title
First name *
Family name  *
Email *
Organisation *
Job title  *
Dietary requirements 
Clear selection
Submit
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy